Send the following on WhatsApp
Continue to ChatJP Morgan 2022 亮點:Amgen 加入小分子標靶藥研發、羅氏續投癌症檢測平台、bluebird 專注基因療法、AbbVie 重申明星藥銷售額 https://geneonline.news/jpmorgan2022-amgen-roche-bluebird-abbvie/
JP Morgan 2022 亮點:Amgen 加入小分子標靶藥研發、羅氏續投癌症檢測平台、bluebird 專注基因療法、AbbVie 重申明星藥銷售額 https://geneonline.news/jpmorgan2022-amgen-roche-bluebird-abbvie/